Patent Assignment
Reel/Frame 067732/0146
RELEASE OF SECURITY INTEREST
Recorded: 2024-06-14
Received: 2024-06-14
Pages: 13
Assignor
SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
Executed: 2024-06-13
Assignee
GPB SCIENTIFIC, INC.
2715 LOKER AVE W, CARLSBAD, CA, 92010, UNITED STATES
Covered Applications
(43)
SYSTEMS AND METHODS FOR PARTICLE SEPARATION AND CONCENTRATION
App. No. 18/261,748
→
ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES
App. No. 17/952,701
→
PREVENTION OF PLATELET ACTIVATION AND CELL DIFFERENTIATION DURING THE PROCESSING OF BLOOD AND BLOOD-RELATED COMPOSITIONS
App. No. 17/793,626
→
DIAGNOSIS OF FETAL ABNORMALITIES USING POLYMORPHISMS INCLUDING SHORT TANDEM REPEATS
App. No. 17/850,599
→
MICROFLUIDIC CARTRIDGES FOR PROCESSING PARTICLES AND CELLS
App. No. 17/788,697
→
METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
App. No. 17/732,227
→
METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
App. No. 17/732,230
→
Methods For The Diagnosis Of Fetal Abnormalities
App. No. 17/671,161
→
ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE THERAPEUTICALLY ACTIVE CELLS
App. No. 17/627,353
→
Methods for Preparing Therapeutically Active Cells Using Microfluidics
App. No. 17/467,385
→
CELL POPULATIONS WITH IMPROVED PRODUCTION AND THERAPEUTIC CHARACTERISTICS
App. No. 17/425,935
→
Combined Purification and Concentration by Deterministic Lateral Displacement With Recirculation of Product
App. No. 17/054,097
→
Methods for Preparing Therapeutically Active Cells Using Microfluidics
App. No. 17/192,691
→
METHODS AND DEVICES FOR MULTI-STEP CELL PURIFICATION AND CONCENTRATION
App. No. 17/168,081
→
MICROFLUIDIC METHODS FOR THE PREPARATION OF CELLS
App. No. 17/258,716
→
Devices And Method For Enrichment And Alteration Of Cells And Other Particles
App. No. 17/021,100
→
Methods for Preparing Therapeutically Active Cells Using Microfluidics
App. No. 17/009,797
→
Methods for Preparing Therapeutically Active Cells Using Microfluidics
App. No. 16/662,033
→
Methods for the Diagnosis of Fetal Abnormalities
App. No. 16/594,505
→
DETERMINISTIC LATERAL DISPLACEMENT IN THE PREPARATION OF CELLS AND COMPOSITIONS FOR THERAPEUTIC USES
App. No. 16/343,754
→
Methods for Preparing Therapeutically Active Cells Using Microfluidics
App. No. 16/108,365
→
Methods for the Diagnosis of Fetal Abnormalities
App. No. 16/046,047
→
Devices And Method For Enrichment And Alteration Of Cells And Other Particles
App. No. 15/965,128
→
METHODS AND DEVICES FOR MULTI-STEP CELL PURIFICATION AND CONCENTRATION
App. No. 15/595,548
→
METHODS AND SYSTEMS FOR PROCESSING PARTICLES
App. No. 15/329,753
→
TAGGED LIGANDS FOR ENRICHMENT OF RARE ANALYTES FROM A MIXED SAMPLE
App. No. 14/995,894
→
Devices And Method For Enrichment And Alteration Of Cells And Other Particles
App. No. 14/930,313
→
ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES
App. No. 14/774,268
→
METHODS FOR THE DIAGNOSIS OF FETAL ABNORMALITIES
App. No. 14/705,239
→
Rare Cell Analysis Using Sample Splitting And DNA Tags
App. No. 14/697,372
→
RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS
App. No. 13/835,926
→
RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS
App. No. 13/837,974
→
DIAGNOSIS OF FETAL ABNORMALITIES USING POLYMORPHISMS INCLUDING SHORT TANDEM REPEATS
App. No. 13/830,871
→
RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS
App. No. 13/829,971
→
FETAL ANEUPLOIDY DETECTION BY SEQUENCING
App. No. 13/794,503
→
Devices And Method For Enrichment And Alteration Of Cells And Other Particles
App. No. 13/452,054
→
DEVICES AND METHOD FOR ENRICHMENT AND ALTERATION OF CELLS AND OTHER PARTICLES
App. No. 13/232,781
→
FETAL CELL ANALYSIS USING SAMPLE SPLITTING
App. No. 12/230,628
→
TAGGED LIGANDS FOR ENRICHMENT OF RARE ANALYTES FROM A MIXED SAMPLE
App. No. 12/037,077
→
RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS
App. No. 11/763,421
→
METHODS FOR THE DIAGNOSIS OF FETAL ABNORMALITIES
App. No. 11/763,245
→
DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CELLS AND OTHER PARTICLES
App. No. 11/449,149
→
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
App. No. 11/322,791
→